Atlas Trials

Do-Youn Oh

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Do-Youn Oh

RecordFirmDate
Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer (NCT03572400)Do-Youn Oh2018-11-29
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer (NCT03579784)Do-Youn Oh2018-11-26

Track Do-Youn Oh automatically

Every clearance here is in the API, with alerts when new ones post.